- Home
- MTVA vs TOMZ Comparison
MTVA vs TOMZ Comparison
Compare MTVA & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- TOMZ
- Stock Information
- Founded
- MTVA 2014
- TOMZ 1979
- Country
- MTVA United States
- TOMZ United States
- Employees
- MTVA N/A
- TOMZ N/A
- Industry
- MTVA
- TOMZ Diversified Commercial Services
- Sector
- MTVA
- TOMZ Finance
- Exchange
- MTVA NYSE
- TOMZ Nasdaq
- Market Cap
- MTVA 15.1M
- TOMZ 16.0M
- IPO Year
- MTVA N/A
- TOMZ N/A
- Fundamental
- Price
- MTVA $0.69
- TOMZ $1.06
- Analyst Decision
- MTVA Strong Buy
- TOMZ Strong Buy
- Analyst Count
- MTVA 2
- TOMZ 1
- Target Price
- MTVA $7.50
- TOMZ $3.50
- AVG Volume (30 Days)
- MTVA 599.8K
- TOMZ 34.2K
- Earning Date
- MTVA 05-14-2025
- TOMZ 07-31-2025
- Dividend Yield
- MTVA N/A
- TOMZ N/A
- EPS Growth
- MTVA N/A
- TOMZ N/A
- EPS
- MTVA N/A
- TOMZ N/A
- Revenue
- MTVA N/A
- TOMZ $8,201,313.00
- Revenue This Year
- MTVA N/A
- TOMZ $3.66
- Revenue Next Year
- MTVA N/A
- TOMZ $139.63
- P/E Ratio
- MTVA N/A
- TOMZ N/A
- Revenue Growth
- MTVA N/A
- TOMZ 19.09
- 52 Week Low
- MTVA $0.63
- TOMZ $0.60
- 52 Week High
- MTVA $5.30
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- TOMZ 63.21
- Support Level
- MTVA N/A
- TOMZ $1.09
- Resistance Level
- MTVA N/A
- TOMZ $1.20
- Average True Range (ATR)
- MTVA 0.00
- TOMZ 0.08
- MACD
- MTVA 0.00
- TOMZ 0.03
- Stochastic Oscillator
- MTVA 0.00
- TOMZ 67.44
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.